ZANOVELLO, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.319
AS - Asia 4.690
EU - Europa 2.982
AF - Africa 1.171
SA - Sud America 1.041
OC - Oceania 111
Continente sconosciuto - Info sul continente non disponibili 49
Totale 23.363
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.739
SG - Singapore 1.648
CN - Cina 1.072
BR - Brasile 648
HK - Hong Kong 509
DE - Germania 397
IT - Italia 357
VN - Vietnam 293
FI - Finlandia 282
SE - Svezia 212
UA - Ucraina 177
GB - Regno Unito 150
RU - Federazione Russa 143
PL - Polonia 135
FR - Francia 124
KR - Corea 87
IN - India 71
AR - Argentina 70
NL - Olanda 68
CI - Costa d'Avorio 60
AT - Austria 56
IE - Irlanda 55
JP - Giappone 55
ZA - Sudafrica 52
EC - Ecuador 49
TR - Turchia 48
ES - Italia 46
KH - Cambogia 46
CH - Svizzera 45
CA - Canada 44
IQ - Iraq 44
AO - Angola 42
UZ - Uzbekistan 42
AL - Albania 41
CO - Colombia 41
HU - Ungheria 41
CR - Costa Rica 40
ID - Indonesia 40
AZ - Azerbaigian 39
TN - Tunisia 39
JO - Giordania 38
EE - Estonia 37
HN - Honduras 37
SI - Slovenia 37
CL - Cile 36
PE - Perù 36
RE - Reunion 36
AE - Emirati Arabi Uniti 35
PY - Paraguay 35
RO - Romania 35
UY - Uruguay 35
GT - Guatemala 34
MA - Marocco 34
ME - Montenegro 34
SA - Arabia Saudita 34
YT - Mayotte 34
GR - Grecia 33
MX - Messico 33
RS - Serbia 33
ZM - Zambia 33
BG - Bulgaria 32
BJ - Benin 32
BY - Bielorussia 32
IR - Iran 32
JM - Giamaica 32
KG - Kirghizistan 32
LY - Libia 32
MD - Moldavia 32
VE - Venezuela 32
BB - Barbados 31
BE - Belgio 31
CW - ???statistics.table.value.countryCode.CW??? 31
DK - Danimarca 31
DO - Repubblica Dominicana 31
DZ - Algeria 31
LU - Lussemburgo 31
PH - Filippine 31
UG - Uganda 31
BO - Bolivia 30
GN - Guinea 30
IL - Israele 30
LA - Repubblica Popolare Democratica del Laos 30
MU - Mauritius 30
RW - Ruanda 30
BF - Burkina Faso 29
BZ - Belize 29
GE - Georgia 29
GH - Ghana 29
NP - Nepal 29
PK - Pakistan 29
TH - Thailandia 29
TJ - Tagikistan 29
BW - Botswana 28
CZ - Repubblica Ceca 28
EG - Egitto 28
GF - Guiana Francese 28
HR - Croazia 28
PA - Panama 28
TZ - Tanzania 28
CV - Capo Verde 27
Totale 22.048
Salva come PNG Salva come JPEG
Città #
Fairfield 1.641
Woodbridge 1.403
Ashburn 1.149
Houston 1.107
Chandler 1.009
Ann Arbor 983
Singapore 900
Jacksonville 640
Seattle 593
Wilmington 587
Cambridge 569
Hong Kong 476
Beijing 311
Princeton 275
Boardman 245
San Diego 224
Santa Clara 168
Padova 165
Nanjing 117
Des Moines 112
Helsinki 109
Los Angeles 97
Bytom 89
Dong Ket 81
Roxbury 78
Medford 76
Ho Chi Minh City 73
Munich 64
Hefei 61
Abidjan 57
Seoul 51
New York 46
São Paulo 46
Phnom Penh 45
Guangzhou 43
Hanoi 43
Chicago 42
Hebei 41
Dublin 40
Amman 37
Nanchang 37
Baku 36
Vienna 34
London 33
Luanda 33
Tashkent 33
Kampala 31
Lusaka 31
Montevideo 31
San José 31
Conakry 30
Cotonou 29
Accra 28
Bridgetown 28
Kigali 28
Milan 28
Shenyang 28
Tokyo 28
Bishkek 27
Buffalo 27
Podgorica 27
Norwalk 26
Ouagadougou 26
Tallinn 26
Andorra la Vella 25
Dushanbe 25
Kingston 25
Lima 25
Nouakchott 25
Panama City 25
Tbilisi 25
Vientiane 25
Willemstad 25
Johannesburg 24
Kingstown 24
Nairobi 24
Nuremberg 24
Brooklyn 23
Castries 23
Dallas 23
Nassau 23
Sofia 23
Tianjin 23
Belo Horizonte 22
Cayenne 22
Dakar 22
Dili 22
Havana 22
Minsk 22
Praia 22
Changsha 21
Harare 21
Jiaxing 21
Ljubljana 21
Luxembourg 21
Mamoudzou 21
Antananarivo 20
Dar es Salaam 20
Guatemala City 20
Kharkiv 20
Totale 15.428
Salva come PNG Salva come JPEG
Nome #
A circulating miRNA assay as a first-line test for prostate cancer screening 280
T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells 277
Cellular pharmacology of PNU-159682, a liver microsomal metabolite of methoxymorpholinyl doxorubicin (Nemorubicin; MMDX) 264
Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. 262
A coordinate deregulation of microRNAs expressed in mucosa adjacent to tumor predicts relapse after resection in localized colon cancer 261
A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors 259
WT1 loss attenuates the TP53-induced DNA damage response in T-cell acute lymphoblastic leukemia 247
A paclitaxel-hyaluronan bioconjugate targeting ovarian cancer affords a potent in vivo therapeutic activity. 246
Reverse immunoediting: When immunity is edited by antigen 237
MiR-142-3p Prevents Macrophage Differentiation during Cancer-Induced Myelopoiesis 228
A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells 225
MODULATION OF MICRORNA EXPRESSION IN HUMAN T CELL DEVELOPMENT: TARGETING OF NOTCH3 BY MIR-150 219
Cytokines for the induction of antitumor effectors: The paradigm of Cytokine-Induced Killer (CIK) cells 211
Reconstruction of gene regulatory modules from RNA silencing of IFN-α modulators: Experimental set-up and inference method 210
Formation and antitumor activity of PNU-159682, a major metabolite of nemorubicin in human liver microsomes 208
Biodistribution imaging of a paclitaxel-hyaluronan bioconjugate 205
Silencing of miR-182 is associated with modulation of tumorigenesis through apoptosis induction in an experimental model of colorectal cancer 202
Circulating miRNA-375 as a potential novel biomarker for active Kaposi’s sarcoma in AIDS Patients 202
Drug conjugation to hyaluronan widens therapeutic indications for ovarian cancer 201
Immunogenetic aspects of erosive osteoarthritis of the hand in patients from northern Italy 200
Clonal heterogeneity of melanoma in a paradigmatic case study: future prospects for circulating melanoma cells 200
A site-selective hyaluronan-interferonα2a conjugate for the treatment of ovarian cancer 198
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma 195
Small noncoding RNAs in cells transformed by human T-cell leukemia virus type 1: a role for a tRNA fragment as a primer for reverse transcriptase. 193
Cross-talk between GLI transcription factors and FOXC1 promotes T-cell acute lymphoblastic leukemia dissemination 192
Anti-L-selectin monoclonal antibody treatment in mice enhances tumor growth by preventing CTL sensitization in peripheral lymph nodes draining the tumor area 190
Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1 188
Cancer rejection by the immune system: forcing the check-points of tumor immune escape. 186
Role of microRNAs in HTLV-1 infection and transformation 184
Glycolytic Phenotype and AMP Kinase Modify the Pathologic Response of Tumor Xenografts to VEGF Neutralization 184
A paclitaxel-hyaluronan bioconjugate exerts a high in vivo therapeutic activity against ovarian cancer 184
Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression 181
Myeloid-derived suppressor cell role in tumor-related inflammation 178
Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies 176
Interaction of lymphokine-activated killer cells with susceptible targets does not induce second messenger generation and cytolytic granule exocytosis 175
DNA immunization in mice against virus-induced tumor antigens. 175
Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST) 174
A gene expression signature associated with survival in metastatic melanoma 173
Immune response to Moloney-murine leukemia virus-induced antigens in bone marrow 170
Human miRNome profiling in colorectal cancer and liver metastasis development 168
Dissecting the molecular regulatory networks in human myeloid-derived suppressor cells 167
An integrative framework identifies alternative splicing events in colorectal cancer development. 167
Characterization of Clinical and Molecular Features Related to the Downregulated Expression of μ-Protocadherin in Colorectal Cancer. 167
CTL response and protection against P815 tumor challenge in mice immunized with DNA expressing the tumor-specific antigen P815A. 165
Natural history of M-MSV tumors in mice carrying endogenized Moloney leukemia virus. 164
HYTAD1-p20: A new paclitaxel-hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer 163
CTL Analysis for Tumor Vaccines. 163
Lack of T-cell mediated cytotoxicity in M-MSV system depending on H-2 haplotypes. 161
Effective genetic vaccination with a widely shared endogenous retroviral tumor antigen requires CD40 stimulation during tumor rejection phase. 160
Individual analysis of mice vaccinated against a weakly immunogenic self tumor-specific antigen reveals a correlation between CD8 T cell response and antitumor efficacy 159
Study of Some Early Immunological Parameters In Aging Humans 159
Melanoma-restricted genes 159
Role of arginine metabolism in immunity and immunopathology. 159
DNA-based vaccination against tumors expressing the P1A antigen 158
miR-22-3p Negatively Affects Tumor Progression in T-Cell Acute Lymphoblastic Leukemia 158
Delivery of methoxymorpholinyl doxorubicin by interleukin 2-activated NK cells: effect in mice bearing hepatic metastases 156
Reprogramming T Lymphocytes for Melanoma Adoptive Immunotherapy by T-Cell Receptor Gene Transfer with Lentiviral Vectors 154
Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells 151
L-arginine metabolism in myeloid cells controls T-lymphocyte functions 151
MAGE, BAGE and GAGE gene expression in human rhabdomyosarcomas 151
ADOPTIVE TRANSFER OF LYMPHOKINE-ACTIVATED KILLER-CELLS LOADED WITH 4'-DEOXY-4'-IODODOXORUBICIN - THERAPEUTIC EFFECT IN MICE BEARING LUNG METASTASES 150
Tolerance to viral antigens in Mov-13 mice carrying endogenized Moloney-murine leukemia virus. 150
Calcium and Inositolphosphates In the Activation of T-cell-mediated Cytotoxicity 150
Regulation of immune responses by L- arginine metabolism 149
Derangement of immune responses by myeloid suppressor cells 148
Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination 148
ANTITUMOR EFFICACY OF LYMPHOKINE-ACTIVATED KILLER-CELLS LOADED WITH RICIN AGAINST EXPERIMENTALLY INDUCED LUNG METASTASES 147
Chemotactic Cues for NOTCH1-Dependent Leukemia 147
Protein tyrosine kinases and phosphatases control apoptosis induced by extracellular adenosine 5'-triphosphate. 147
Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells 146
Virus-Specific Cytotoxic CD4+ T Cells for the Treatment of EBV-Related Tumors. 146
Lack of M-MuSV tumour regression associated with T lymphocyte tolerance. 145
Tumor-induced immune dysfunctions caused by myeloid suppressor cells 144
Immunotherapy for EBV-associated malignancies 144
Myeloid-derived suppressor cell heterogeneity and subset definition 144
GM-CSF and IL-6 induce tolerogenic myeloid-derived suppressor cells through C/EBP beta and allow long term islet allograft survival 144
Adoptive cell therapy against EBV-related malignancies: a survey of clinical results 144
Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150 142
Role of infectious virus expression and immune response in retrovirus-induced oncogenesis. 142
Crosstalk between Hedgehog pathway and the glucocorticoid receptor pathway as a basis for combination therapy in T-cell acute lymphoblastic leukemia 142
Peritoneal tumor carcinomatosis: pharmacological targeting with hyaluronan-based bioconjugates overcomes therapeutic indications of current drugs. 139
Common cancer biomarkers 138
Tumor-Induced Tolerance and Immune Suppression Depend on the C/EBPbeta Transcription Factor. 138
Responsiveness to hedgehog pathway inhibitors in t-cell acute lymphoblastic leukemia cells is highly dependent on 5′ amp-activated kinase inactivation 138
Extracellular ATP as a possible mediator of cell-mediated cytotoxicity 137
Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: A novel target for therapeutic intervention 137
CD45 regulates apoptosis induced by extracellular adenosine triphosphate and cytotoxic T lymphocytes 137
In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer 136
INHIBITION OF PROTEIN-TYROSINE PHOSPHORYLATION PREVENTS T-CELL-MEDIATED CYTOTOXICITY 136
Extracellular ATP causes lysis of mouse thymocytes and activates a plasma membrane ion channel 135
Therapeutic effect of interleukin 12 on mouse haemangiosarcomas is not associated with an increased anti-tumour cytotoxic T-lymphocyte activity 135
Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes 134
Functional activityin vivo of effector T cell populations III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone 134
IL4R alpha(+) Myeloid-Derived Suppressor Cell Expansion in Cancer Patients 134
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice 134
Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma 133
Functional avidity-driven activation-induced cell death shapes CTL immunodominance. 132
Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism 131
Optimization of a DNA vaccination protocol for CTL induction against tumors expressing the weakly immunogenic P1A antigen 130
Cancer gene therapy by DNA immunization 130
Totale 17.117
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.532
article - articoli 71.430
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 812
Totale 145.774
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.186 0 0 0 0 0 123 59 198 244 184 201 177
2021/20222.385 68 302 350 146 80 164 201 214 87 47 290 436
2022/20231.901 403 234 56 232 290 259 10 116 187 15 68 31
2023/2024855 48 107 91 55 84 100 73 62 31 27 80 97
2024/20253.163 24 166 140 119 463 143 124 294 298 132 498 762
2025/20266.906 461 1.184 1.815 2.202 1.142 102 0 0 0 0 0 0
Totale 23.435